Exactly What’s Ahead For Healthcare In 2017?

Two of health cares greatest stories this year might finishwind up being the planned launch of two brand-new gene-sequencing machines fromIllumina, Inc.(NASDAQ: ILMN), and also the prospective authorization ofKite Pharmas(NASDAQ: KITE) chimeric antigen receptor T-cell therapy. Are you planned for the possible possibility associated with these two stories? In this episode of The Motley Fools Sector Emphasis: Healthcare Opens a New Window. podcast, analyst Kristine Harjes is joined by contributor Todd Campbell to describe why these business can be wise investments.

Just what’s Ahead for Medical care in 2017? Two of medical cares most significant tales this year might finish up being the prepared launch of two brand-new gene-sequencing devices fromIllumina, Inc.(NASDAQ: ILMN), as well as the possible authorization ofKite Pharmas(NASDAQ: KITE) chimeric antigen receptor T-cell therapy. In this episode of The Motley Fools Market Emphasis: Healthcare Opens a New Window.